WebMD Health Corp. to Launch Enhanced Version of Apple Watch App
Apr 24 15
WebMD Health Corp. has announced plans to launch an enhanced version of its mobile app for Apple Watch, which includes a new Medication Reminder feature. WebMD's Apple Watch app will enable consumers to view daily medication schedules and instructions, as well as pill images with dosage and timing information, plus receive reminders when it's time to take a given medication - right on their Apple Watch. When users open the WebMD Apple Watch app, they'll see their daily medication schedule and information about whether or not they've taken a required dose. They will also be able to read medication instructions, such as whether to take a pill with food, and access additional in-depth information on their iPhone via Handoff. Each "Medication Reminder" notification includes customizable pill images, as well as dosage and timing information. When users are prompted to take a given medication, they are asked to log one of four possible actions: take the medication; skip the medication; snooze; and dismiss the reminder. When a user chooses "Snooze," they will be reminded to take the medication again after 15 minutes. If a user chooses to "Dismiss" a given reminder, they will receive an alert at the time of the next scheduled dose. WebMD's "Glance" delivers an entirely new way for users to receive information about their medication regimen. The Glance lets users know what time to take their next scheduled dose (e.g. 12:00 PM), or if that user is scheduled to take a dose within two hours or less, they will receive a message (e.g. "Next dose in 59 minutes") instead of the time. If the time for the last scheduled dose of the day has passed, the Glance is updated to show whether the final dose was "Taken", "Missed" or "Skipped". These innovations extend the functionality of WebMD's app for iPhone while delivering an innovative way to interact-right from your wrist. "The Apple Watch is an immensely personal device that provides WebMD with an unprecedented opportunity to influence patient compliance," said Benjamin Greenberg, vice president of Product Management & User Experience at WebMD. "Additionally, the Watch's Long-Look notifications enable WebMD to display medication and dosage information more directly and discreetly than on any other platform, keeping the user's experience simple while helping to protect the privacy of their sensitive health information." WebMD's enhanced app with Medication Reminders will be available for download in the Apple Watch App Store beginning April 24.
WebMD Health Corp. Presents at Mid-America Healthcare Venture Forum, Mar-10-2015 11:40 AM
Mar 10 15
WebMD Health Corp. Presents at Mid-America Healthcare Venture Forum, Mar-10-2015 11:40 AM. Venue: Fairmont Chicago, Millennium Park, 200 North Columbus Drive, Chicago, IL 60601, United States. Speakers: Dave Chase, Senior Vice President.
WebMD Health Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter Ending March 31, 2015 and Year Ending December 31, 2015
Feb 24 15
WebMD Health Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenue of $162,727,000 compared to $146,277,000 a year ago. Income from continuing operations before income tax provision was $26,390,000 compared to $19,270,000 a year ago. Income from continuing operations was $15,154,000 compared to $10,812,000 a year ago. Net income was $16,276,000 or $0.38 per diluted share compared to $10,812,000 or $0.25 per diluted share a year ago. Adjusted EBITDA was $48,138,000 compared to $40,636,000 a year ago. Capital expenditures were $5 million. Operating cash flow from continuing operations was approximately $35 million for the fourth quarter, which includes a cash tax benefit of $2 million related to the use of tax NOLs, generated by a stock-based compensation.
For the year, the company reported revenue of $580,449,000 compared to $515,293,000 a year ago. Income from continuing operations before income tax provision was $71,648,000 compared to $28,756,000 a year ago. Income from continuing operations was $40,941,000 compared to $15,116,000 a year ago. Net income was $42,063,000 or $1.00 per diluted share compared to $15,116,000 or $0.31 per diluted share a year ago. Adjusted EBITDA was $158,622,000 compared to $122,886,000 a year ago. Net cash provided by operating activities was $113,152,000 compared to $86,094,000 a year ago. Purchases of property and equipment were $23,194,000 compared to $22,341,000 a year ago.
The company provided earnings guidance for the first quarter ending March 31, 2015 and year ending December 31, 2015. For the year, the company expects revenue of $486.0 million to $502.0 million, adjusted EBITDA of $180.0 million to $190.0 million, pre-tax income of $85.0 million to $100.0 million and net income of $50.5 million to $59.5 million. Diluted per share expects to be $1.23 to $1.35. The company expects capital expenditures to be approximately $45 million to $55 million.
For the first quarter ending March 31, 2015, the company expects revenue expects to be $141 million to $143 million. Adjusted EBITDA is forecasted to be between $37 million to $38 million and net income is forecasted to be between $8.5 million to $9.5 million.